Neurosurgical intervention after intracerebral haemorrhage: data from the Tranexamic acid for Intracerebral Haemorrhage 2 (TICH-2) Trial

被引：0
|
作者：
Hollingworth, M. [1 ]
Woodhouse, L. [2 ]
Law, Z. K. [2 ]
Munshi, S. [3 ]
Krishan, K. [2 ,3 ]
Bath, P. M. [2 ,3 ]
Sprigg, N. [2 ,3 ]
机构：
[1] Nottingham Univ Hosp NHS Trust, Dept Neurosurg, Nottingham, England
[2] Univ Nottingham, Div Clin Neurosci, Nottingham, England
[3] Nottingham Univ Hosp NHS Trust, Nottingham, England
来源：
INTERNATIONAL JOURNAL OF STROKE | 2019年 / 14卷 / 4_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
081
引用
收藏
页码：26 / 27
页数：2
相关论文
共 50 条
  • [21] Patients From the Tranexamic Acid for Hyperacute Intracerebral Haemorrhage (TICH-2) Trial Suffering From Hyperglycaemia at Baseline; Their Characteristics and Day 90 Outcomes
    Sprigg, Nikola
    Robson, Katie
    Bath, Philip M.
    STROKE, 2016, 47
  • [22] ANAEMIA AT BASELINE CAN PREDICT POOR FUNCTIONAL OUTCOME: DATA FROM THE ONGOING TRANEXAMIC ACID FOR HYPERACUTE PRIMARY INTRACEREBRAL HAEMORRHAGE (TICH-2) TRIAL
    Robson, K.
    Appleton, J.
    Bath, P.
    Sprigg, N.
    INTERNATIONAL JOURNAL OF STROKE, 2016, 11 (SUPP 3) : 70 - 70
  • [23] Patients from the Tranexamic acid for hyperacute IntraCerebral Haemorrhage (TICH-2) trial suffering from hyperglycaemia at baseline: Their characteristics and day 90 outcomes
    Robson, K.
    Krishnan, K.
    Bath, P.
    Sprigg, N.
    INTERNATIONAL JOURNAL OF STROKE, 2015, 10 : 15 - 15
  • [24] Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial
    Sprigg, Nikola
    Flaherty, Katie
    Appleton, Jason P.
    Salman, Rustam Al-Shahi
    Bereczki, Daniel
    Beridze, Maia
    Christensen, Hanne
    Ciccone, Alfonso
    Collins, Ronan
    Czlonkowska, Anna
    Dineen, Robert A.
    Duley, Lelia
    Jose Egea-Guerrero, Juan
    England, Timothy J.
    Krishnan, Kailash
    Laska, Ann Charlotte
    Law, Zhe Kang
    Ozturk, Serefnur
    Pocock, Stuart J.
    Roberts, Ian
    Robinson, Thompson G.
    Roffe, Christine
    Seiffge, David
    Scutt, Polly
    Thanabalan, Jegan
    Werring, David
    Whynes, David
    Bath, Philip M.
    LANCET, 2018, 391 (10135): : 2107 - 2115
  • [25] Incidence, risk factors and outcomes of seizures in intracerebral haemorrhage: interim analysis from the TICH-2 trial
    Law, Z. K.
    Flaherty, K.
    Appleton, J. P.
    Scutt, P.
    England, T. J.
    Bath, P. M.
    Sprigg, N.
    INTERNATIONAL JOURNAL OF STROKE, 2017, 12 : 48 - 48
  • [26] EFFECT OF PRIOR ANTIPLATELET THERAPY ON HAEMATOMA CHARACTERISTICS AND FUNCTIONAL OUTCOME: A SUBGROUP ANALYSIS OF THE TRANEXAMIC ACID IN INTRACEREBRAL HAEMORRHAGE-2 (TICH-2) TRIAL
    Law, Z. K.
    Flaherty, K.
    Scutt, P.
    Appleton, J.
    Bath, P.
    Sprigg, N.
    INTERNATIONAL JOURNAL OF STROKE, 2018, 13 : 4 - 5
  • [27] Tranexamic acid for acute intracerebral haemorrhage (TICH): Results of the first randomised controlled trial
    Sprigg, N.
    Renton, C.
    Kwong, Y.
    Dineen, R.
    Bath, P. M.
    INTERNATIONAL JOURNAL OF STROKE, 2012, 7 : 7 - 7
  • [28] Use of Do Not Attempt Resuscitation (DNAR) forms early in haemorrhagic stroke: Data from the ongoing Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2) study
    Robson, K.
    Krishnan, K.
    Bath, P.
    Sprigg, N.
    INTERNATIONAL JOURNAL OF STROKE, 2015, 10 : 14 - 14
  • [29] Use of Do Not Attempt Resuscitation (DNAR) Forms Early in Haemorrahgic Stroke: Data From the Ongoing Tranexamic Acid for Hyperacute Primary Intracerebral Haemorrhage (TICH-2) Study
    Sprigg, Nikola
    Robson, Katie
    Bath, Philip M.
    STROKE, 2016, 47
  • [30] Baseline characteristics of patients enrolled in the tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH 2) study
    Robson, K.
    Sprigg, N.
    Krishnan, K.
    Bath, P.
    INTERNATIONAL JOURNAL OF STROKE, 2014, 9 : 14 - 14
12345